Bibliographic Details
Title: |
A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer |
Authors: |
Kotecha, Ritesh R., Doshi, Sahil D., Knezevic, Andrea, Chaim, Joshua, Chen, Yingbei, Jacobi, Rachel, Zucker, Mark, Reznik, Ed, McHugh, Deaglan, Shah, Neil J., Feld, Emily, Aggen, David H., Rafelson, William, Xiao, Han, Carlo, Maria I., Feldman, Darren R., Lee, Chung-Han, Motzer, Robert J., Voss, Martin H. |
Source: |
In European Urology Oncology August 2024 7(4):804-811 |
Database: |
ScienceDirect |